Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1777 - 1784 of 11442 results
Digital Health Companies Hit With Securities Fraud Suits
June 20, 2022| News
Vet Clinic FTC Settlement Puts Private Equity On Notice
June 17, 2022| Blog| Viewpoint
In Honor of Juneteenth: Bob Bodian’s Address to Colleagues
June 17, 2022| Blog| Viewpoint
Private Equity On Notice Due To Vet Clinic FTC Settlement
June 16, 2022| News
The Supreme Court Strikes a Blow to PAGA: What California Employers Need to Know
June 16, 2022| Blog| Viewpoint
Remote-Controlled Robotics
June 15, 2022| Blog| Viewpoint
Health Law Diagnosed – Digital Health During the PHE and Beyond: Leveraging Telehealth to Address Disparities in Access to Care
June 14, 2022| Podcast| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.